1. Combined Pan‐HER and ALK/ROS1/MET Inhibition with Dacomitinib and Crizotinib in Advanced Non–Small Cell Lung Cancer: Results of a Phase I Study. Issue 5 (May 2016) Authors: Jänne, Pasi A.; Shaw, Alice T.; Camidge, Ross D.; Giaccone, Giuseppe; Shreeve, Martin S.; Tang, Yiyun; Goldberg, Zelanna; Martini, Jean‐François; Xu, Huiping; James, Leonard P.; Solomon, Benjamin J. Journal: Journal of thoracic oncology Issue: Volume 11:Issue 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗